@article{6b55b459ac1240e6b32f442202da3758,
title = "Standardization of flow cytometric minimal residual disease assessment in international clinical trials - a feasibility study from the European Myeloma Network",
keywords = "Feasibility Studies, Flow Cytometry, Humans, Multiple Myeloma/diagnosis, Neoplasm, Residual, Reference Standards",
author = "\{Op Bruinink\}, \{Davine Hofste\} and Stefania Oliva and Lucie Rihova and Alexander Schmitz and Milena Gilestro and \{Te Marvelde\}, Jeroen and Romana Kralova and Helle H{\o}holt and Annemiek Broijl and Johnsen, \{Hans Erik\} and Roman Hajek and Mario Boccadoro and Pieter Sonneveld and Paola Omed{\`e} and \{Van der Velden\}, \{Vincent H.J.\} and \{European Myeloma Network\}",
note = "Copyright: This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine",
year = "2021",
month = may,
doi = "10.3324/haematol.2020.267831",
language = "English",
volume = "106",
pages = "1496--1499",
journal = "Haematologica",
issn = "0390-6078",
publisher = "Ferrata Storti Foundation",
number = "5",
}